Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Steinman

Showing results (51-60 of 335) with videos related to

Pageof 34
Sort By:
Science (New York, N.Y.)|June 11, 2002
Altered peptide ligands and MS treatmentPaul Conlon, Lawrence Steinman
Nature Reviews. Immunology|May 31, 2003
Transcriptional analysis of targets in multiple sclerosisLawrence Steinman, Scott Zamvil
Neuron|October 21, 2009
Innate and adaptive autoimmunity directed to the central nervous systemRoopa Bhat, Lawrence Steinman
Journal of the Neurological Sciences|May 10, 2006
Nogo in multiple sclerosis: growing roles of a growth inhibitorPaulo Fontoura, Lawrence Steinman
Journal of Autoimmunity|October 14, 2014
From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael SelaLawrence Steinman, Yehuda Shoenfeld
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2017
T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and AutoimmunityReinhard Hohlfeld, Lawrence Steinman
Nature Medicine|March 5, 2005
Multiple sclerosis: trapped in deadly glueMichael Platten, Lawrence Steinman
Nature Immunology|August 23, 2006
At once harmful and beneficial: the dual properties of NF-kappaBSawsan Youssef, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2025
Epstein-Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imagingNoga Orr, Lawrence Steinman
Current Neurology and Neuroscience Reports|April 26, 2006
Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumabAnnette Langer-Gould, Lawrence Steinman
Pageof 34

Showing results (51-60 of 335) with videos related to

Sort By:
Pageof 34
Science (New York, N.Y.)|June 11, 2002
Altered peptide ligands and MS treatmentPaul Conlon, Lawrence Steinman
Nature Reviews. Immunology|May 31, 2003
Transcriptional analysis of targets in multiple sclerosisLawrence Steinman, Scott Zamvil
Neuron|October 21, 2009
Innate and adaptive autoimmunity directed to the central nervous systemRoopa Bhat, Lawrence Steinman
Journal of the Neurological Sciences|May 10, 2006
Nogo in multiple sclerosis: growing roles of a growth inhibitorPaulo Fontoura, Lawrence Steinman
Journal of Autoimmunity|October 14, 2014
From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael SelaLawrence Steinman, Yehuda Shoenfeld
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2017
T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and AutoimmunityReinhard Hohlfeld, Lawrence Steinman
Nature Medicine|March 5, 2005
Multiple sclerosis: trapped in deadly glueMichael Platten, Lawrence Steinman
Nature Immunology|August 23, 2006
At once harmful and beneficial: the dual properties of NF-kappaBSawsan Youssef, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2025
Epstein-Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imagingNoga Orr, Lawrence Steinman
Current Neurology and Neuroscience Reports|April 26, 2006
Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumabAnnette Langer-Gould, Lawrence Steinman
Pageof 34